CTLA4 and neoplasm: Combined blocking of PD-1/PD-L1 and CTLA-4 negative co-stimulatory pathway can make tumor-specific T cells that would otherwise be inactivated continue to expand and play an effective role, thus transforming the tumor microenvironment from an inhibitory state to an immune response state (11).